Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome

Acta Obstetricia et Gynecologica Scandinavica

Volumn 90, Issue 6, 2011, Pages 600-608

  Battaglia, Cesare ^a   Battaglia, Bruno ^a   Mancini, Fulvia ^b   Paradisi, Roberto ^a   Fabbri, Raffaella ^a   Venturoli, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b INSTITUT UNIVERSITARI DEXEUS   (Spain)

Author keywords

Doppler; fat; lipid; metabolism; polycystic ovary; polycystic ovary syndrome; ultrasonography

Indexed keywords

ANDROSTENEDIONE; C PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYPROGESTERONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY FAT DISTRIBUTION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LUTEINIZING HORMONE BLOOD LEVEL; MEDICAL EXAMINATION; OBSERVATIONAL STUDY; OPHTHALMIC ARTERY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUPINE POSITION; TESTOSTERONE BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY FAT DISTRIBUTION; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; ORGAN SIZE; OVARY; POLYCYSTIC OVARY SYNDROME; SUBCUTANEOUS FAT; THINNESS; ULTRASONOGRAPHY, DOPPLER; WAIST-HIP RATIO;

EID: 79956192306     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01124.x     Document Type: Article

References (43)

1. Meyer C, McGrath BP, Teede HJ,. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab. 2005; 90: 5711-6. (Pubitemid 41415480)
2. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH,. Relationship of androgenetic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 1983; 57: 304-10. (Pubitemid 13032480)
3. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F, et al,. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007; 92: 2500-5. (Pubitemid 47037349)
4. Kershaw EE, Flier JS,. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004; 89: 2548-56. (Pubitemid 38766330)
5. Yildrim B, Sabir N, Kaleli B,. Relationship of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003; 79: 1358-64. (Pubitemid 36687882)
6. Good C, Tulchinsky M, Mauger D, Demers LM, Legro RS,. Bone density and body composition in lean women with polycystic ovary syndrome. Fertil Steril. 1999; 72: 21-5. (Pubitemid 29300256)
7. Cenk Sayin N, Gucer F, Balkanli-Kaplan P, Ali Yuce M, Yardim T,. Insulin resisitance and lipid profile in women with polysytic appearing ovaries:implications with regard to polycystic ovary syndrome. Gynecol Endocrinol. 2003; 17: 387-96. (Pubitemid 37338869)
8. Engin-Ustun Y, Ustun Y, Meydanli MM, Kafkasli A, Yetkin G,. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome? Gynecol Endocrinol. 2006; 22: 324-8. (Pubitemid 43941409)
9. Loucks TL, Talbott EO, McHugh KP, Keelan M, Berga SL, Guzick DS,. Do polycystic appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? Fertil Steril. 2000; 74: 547-52.
10. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S,. A novel technique for the determination of body fat by computed tomography. Int J Obes. 1983; 7: 437-45. (Pubitemid 13020976)
11. Seidell JC, Bakker CJ, Van Der Kooy K,. Imaging techniques for measuring adipose-tissue distribution-a comparison between computed tomography and 1.5-T magnetic resonance. Am J Clin Nutr. 1990; 51: 953-7.
12. Lancaster JL, Ghiatas AA, Alyassin A, Kilcoyne RF, Bonora E, DeFronzo RA,. Measurement of abdominal fat with T1-weighted MR images. J Magn Reson Imaging. 1991; 1: 363-9.
13. Gronemeyer SA, Steen RG, Kauffman WM, Reddick WE, Glass JO,. Fast adipose tissue (FAT) assessment by MRI. Magn Reson Imaging. 2000; 18: 815-8.
14. Ribeiro-Filho FF, Faria AN, Kohlmann O Jr, Ajzen S, Ribeiro AB, Zanella MT, et al,. Ultrasonography for the evaluation of visceral fat and cardiovascular risk. Hypertension. 2001; 38: 713-7.
15. Tayama K, Inukai T, Dhimomura Y,. Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1999; 43: 49-58. (Pubitemid 29096411)
16. Meriño-Ibarra E, Artieda M, Cenarro A, Goicoechea J, Calvo L, Guallar A, et al,. Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. Metabolism. 2005; 54: 1230-5. (Pubitemid 41206884)
17. Koda M, Senda M, Kamba M, Kimura K, Murawaki Y,. Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume. Abdom Imaging. 2007; 32: 387-92. (Pubitemid 47077098)
18. Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, et al,. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod. 2008; 23: 153-9. (Pubitemid 351767326)
19. Hirooka M, Kumagi T, Kurose K, Nakanishi S, Michitaka K, Matsuura B, et al,. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med. 2005; 44: 794-9. (Pubitemid 41263822)
20. Soyama A, Nishikawa T, Iahizuka T, Ito H, Saito J, Yagi K, et al,. Clinical usefulness of the thickness of preperitoneal and subcutaneous fat layer in the abdomen estimated by ultrasonography for diagnosing abdominal obesity in each type of impaired glucose tolerance in man. Endocr J. 2005; 52: 229-36. (Pubitemid 40745712)
21. Abe T, Kawakami Y, Sugita M, Yoshikawa K, Fukunaga T,. Use of B-mode ultrasound for visceral fat mass evaluation:comparisons with magnetic resonance imaging. Appl Human Sci. 1995; 14: 133-9.
22. Suzuki R, Watanabe S, Hirai Y, Akiyama K, Nishide T, Matsushima Y, et al,. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med. 1993; 95: 309-14. (Pubitemid 23270289)
23. Battaglia C, Mancini F, Cianciosi A, Busacchi P, Facchinetti F, Reggiani Marchesini G, et al,. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome. Obstet Gynecol. 2008; 111: 385-95. (Pubitemid 351653430)
24. Battaglia C, Artini PG, Salvatori M, Giulini S, Petraglia F, Maxia N, et al,. Ultrasonographic pattern of polycystic ovaries: color Doppler and hormonal correlations. Ultrasound Obstet Gynecol. 1998; 11: 332-6. (Pubitemid 28282407)
25. Ferriman D, Gallwey JD,. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961; 21: 1440-7.
26. Liu KH, Chan YL, Chan WB, Kong WL, Kong MO, Chan JCN,. Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obes Relat Metab Disord. 2003; 27: 1267-73. (Pubitemid 37281676)
27. Battaglia C, Artini PG, D'Ambrogio G, Genazzani AD, Genazzani AR,. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol. 1995; 172: 108-13.
28. Bae JH, Kim WS, Rihal CS, Lerman A,. Individual measurement and significance of carotid intima, media, and intima-media thickness by B-mode ultrasonographic image processing. Arterioscler Thromb Vasc Biol. 2006; 26: 2380-5. (Pubitemid 44465737)
29. Battaglia C, Mancini F, Regnani G, Persico N, Volpe A, de Aloysio D,. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause. 2004; 11: 69-77. (Pubitemid 40362201)
30. Battaglia C, Cianciosi A, Mancini F, Persico N, Sisti G, Facchinetti F, et al,. Angeliq versus Activelle in normotensive postmenopausal women: a prospective, randomized pilot study. Menopause. 2009; 16: 803-9.
31. Friedewald WT, Levy RT, Fredrickson DS,. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502.
32. Modan M, Harris MI, Halkin H,. Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes Care. 1997; 20 (Suppl 1): S1-70.
33. Kalkhoff RK, Hartz AH, Rupley D, Kissebah AH, Kelber S,. Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J Lab Clin Med. 1983; 102: 621-7. (Pubitemid 13013865)
34. Blair D, Habicht JP, Sims EA, Sylwester D, Abraham S,. Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk. Am J Epidemiol. 1984; 119: 526-40. (Pubitemid 14134661)
35. Resnick LM, Militianu D, Cunnings AJ, Pipe JG, Evelhoch JL, Soulen RL,. Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension. 1997; 30: 654-9. (Pubitemid 27444249)
36. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S,. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987; 36: 54-9. (Pubitemid 17016386)
37. Sabir N, Sermez Y, Kazil S, Zencir M,. Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements. Eur J Ultrasound. 2001; 14: 121-8. (Pubitemid 33026505)
38. Nakajima T, Fujioka S, Tokunaga K, Matsuzawa Y, Tarui S,. Correlation of intraabdominal fat accumulation and left ventricular performance in obesity. Am J Cardiol. 1989; 64: 369-73. (Pubitemid 19187675)
39. Grundy SM,. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002; 105: 2696-8. (Pubitemid 34615135)
40. Da Silva AA, Kuo JJ, Tallam LS, Hall JE,. Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension. 2004; 43: 383-7. (Pubitemid 38174143)
41. Alvarez GE, Beske SD, Ballard TP, Davy KP,. Sympathetic neural activation in visceral obesity. Circulation. 2002; 106: 2533-6. (Pubitemid 35340687)
42. 123I-p-iodoamphetamine with single-photon emission computed tomography. J Diabet Compications. 1990; 4: 170-4.
43. Battaglia C, Mancini F, Cianciosi A, Busacchi P, Persico N, Paradisi R, et al,. Cardiovascular risk in normal weight, eumenorrheic, nonhirsute daughters of patients with polycystic ovary syndrome: a pilot study. Fertil Steril. 2009; 92: 240-9.